Fair Balance of Prescription Drug Information on Legitimate and Illegitimate Online Pharmacy Websites

• Published in: Pharmacy Vol. 12; no. 2; p. 67
• Main Authors: Huhmann, Bruce A, Limbu, Yam B
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2024
• Subjects: benefits; Drug stores; Drugs; Evaluation; fair balance; Information services; Information services industry; legitimate online pharmacy; Marketing research; Medical advice systems; Methods; Online pharmacies; Overdose; Patient package inserts; pharmaceutical information; Pharmaceuticals; Pharmacists; Pharmacy; Prescribing; Prescription drugs; risks; Search engines; Services; Web sites; United States; United States > US; benefits; risks; prescription drugs; fair balance; pharmaceutical information; legitimate online pharmacy; illegitimate online pharmacy
• ISSN: 2226-4787; 2226-4787
• DOI: 10.3390/pharmacy12020067

Patients require important information when prescribed medications. For example, the U.S. Food and Drug Administration (FDA) requires that promotional information includes a fair balance of risks and benefits. This study evaluates how well legitimate online pharmacies (LOPs) and illegitimate online pharmacies (IOPs) comply with the spirit of the FDA's fair balance guidelines by examining the extent and equivalence of risk and benefit information on their websites. This study analyzed the content of 307 online pharmacy websites. Most (90.3%) communicated drug benefits, while 84.7% provided risks. Both risk and benefit information was moderately extensive. Presentation of risks and benefits differed between online pharmacy types. Compared to LOPs, IOPs were more likely to present risk information but also exaggerate benefits. Four in ten online pharmacies presented a fair balance of risks and benefits. However, LOPs (47.4%) were more likely to present a fair balance than IOPs (36.5%). Interestingly, IOPs were more likely to disclose instructions for use and overdose information than LOPs. These findings underscore the need for regulatory guidelines to encourage online pharmacies to present a fair balance of benefit and risk information. Also, pharmacists should develop online approaches to better fulfill their professional responsibility as drug information providers while maintaining their integrity and objectivity.